584 related articles for article (PubMed ID: 28951443)
1. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
Cuijpers SAG; Willemstein E; Vertegaal ACO
Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
[TBL] [Abstract][Full Text] [Related]
2. Poly-SUMO-2/3 chain modification of Nuf2 facilitates CENP-E kinetochore localization and chromosome congression during mitosis.
Subramonian D; Chen TA; Paolini N; Zhang XD
Cell Cycle; 2021 May; 20(9):855-873. PubMed ID: 33910471
[TBL] [Abstract][Full Text] [Related]
3. Identification of SUMO-2/3-modified proteins associated with mitotic chromosomes.
Cubeñas-Potts C; Srikumar T; Lee C; Osula O; Subramonian D; Zhang XD; Cotter RJ; Raught B; Matunis MJ
Proteomics; 2015 Feb; 15(4):763-72. PubMed ID: 25367092
[TBL] [Abstract][Full Text] [Related]
4. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
5. RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.
Klein UR; Haindl M; Nigg EA; Muller S
Mol Biol Cell; 2009 Jan; 20(1):410-8. PubMed ID: 18946085
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
[TBL] [Abstract][Full Text] [Related]
7. SUMO targets the APC/C to regulate transition from metaphase to anaphase.
Eifler K; Cuijpers SAG; Willemstein E; Raaijmakers JA; El Atmioui D; Ovaa H; Medema RH; Vertegaal ACO
Nat Commun; 2018 Mar; 9(1):1119. PubMed ID: 29549242
[TBL] [Abstract][Full Text] [Related]
8. Mechanism and function of DNA replication-independent DNA-protein crosslink repair via the SUMO-RNF4 pathway.
Liu JCY; Kühbacher U; Larsen NB; Borgermann N; Garvanska DH; Hendriks IA; Ackermann L; Haahr P; Gallina I; Guérillon C; Branigan E; Hay RT; Azuma Y; Nielsen ML; Duxin JP; Mailand N
EMBO J; 2021 Sep; 40(18):e107413. PubMed ID: 34346517
[TBL] [Abstract][Full Text] [Related]
9. Functional Crosstalk between the PP2A and SUMO Pathways Revealed by Analysis of STUbL Suppressor, razor 1-1.
Nie M; Arner E; Prudden J; Schaffer L; Head S; Boddy MN
PLoS Genet; 2016 Jul; 12(7):e1006165. PubMed ID: 27398807
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
11. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
12. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
Her J; Jeong YY; Chung IK
FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
[TBL] [Abstract][Full Text] [Related]
13. Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.
Hendriks IA; Lyon D; Young C; Jensen LJ; Vertegaal AC; Nielsen ML
Nat Struct Mol Biol; 2017 Mar; 24(3):325-336. PubMed ID: 28112733
[TBL] [Abstract][Full Text] [Related]
14. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
15. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
16. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis.
Zhang XD; Goeres J; Zhang H; Yen TJ; Porter AC; Matunis MJ
Mol Cell; 2008 Mar; 29(6):729-41. PubMed ID: 18374647
[TBL] [Abstract][Full Text] [Related]
17. RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response.
Poulsen SL; Hansen RK; Wagner SA; van Cuijk L; van Belle GJ; Streicher W; Wikström M; Choudhary C; Houtsmuller AB; Marteijn JA; Bekker-Jensen S; Mailand N
J Cell Biol; 2013 Jun; 201(6):797-807. PubMed ID: 23751493
[TBL] [Abstract][Full Text] [Related]
18. Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression.
Rivera O; Sharma M; Dagar S; Shahani N; Ramĺrez-Jarquĺn UN; Crynen G; Karunadharma P; McManus F; Bonneil E; Pierre T; Subramaniam S
Cell Mol Life Sci; 2024 Apr; 81(1):169. PubMed ID: 38589732
[TBL] [Abstract][Full Text] [Related]
19. How Does SUMO Participate in Spindle Organization?
Abrieu A; Liakopoulos D
Cells; 2019 Jul; 8(8):. PubMed ID: 31370271
[TBL] [Abstract][Full Text] [Related]
20. RNF4 interacts with both SUMO and nucleosomes to promote the DNA damage response.
Groocock LM; Nie M; Prudden J; Moiani D; Wang T; Cheltsov A; Rambo RP; Arvai AS; Hitomi C; Tainer JA; Luger K; Perry JJ; Lazzerini-Denchi E; Boddy MN
EMBO Rep; 2014 May; 15(5):601-8. PubMed ID: 24714598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
